Sonrai Analytics
The AI engine Fit Assessment
BetaSonrai Analytics effectively utilizes machine learning to discover new patterns and expand therapeutic options, supporting drug repurposing initiatives.
Blurb
Sonrai Analytics develop applications and interfaces to utilize the data and the resultant outputs of analysis.
HQ Location
Belfast (United Kingdom)
Founded
2018
Employees
11 - 50
Total funding raised
$3.48M
Last Funding Event
Venture - Series Unknown, November 10, 2022
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
- Biomarker Identification
Developer of analytics software designed to elevate data, discover new treatments, or expedite research development. The company's software integrates multi-omic data, advanced AI analytics, and a secure infrastructure for accelerated drug candidate identification and biomarker discovery, enabling precision medicine organizations to streamline research, reduce time-to-market, and improve patient outcomes.